Join
Live feed
·
INSIDERFilingvia Quantisnow
Summit Therapeutics Inc. logo

Co-Chief Executive Officer Zanganeh Mahkam was granted 44,052 shares (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.
SMMT· Summit Therapeutics Inc.
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track SMMT (Summit Therapeutics Inc.) and more on Quantisnow.

Co-Chief Executive Officer Zanganeh Mahkam was granted 44,052 shares (SEC Form 4) | Quantisnow